AI assistant
ANGIODYNAMICS INC — Director's Dealing 2016
Apr 25, 2016
32939_dirs_2016-04-25_8151d127-4ae8-4456-b6d1-b56ee0aa507e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-04-21
Reporting Person: Trowbridge Stephen A (SVP and General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-21 | Common Stock | S | 10500 | $12.33 | Disposed | 32469 | Direct |
| 2016-04-25 | Common Stock | S | 2440 | $12.18 | Disposed | 30029 | Direct |
| 2016-04-25 | Common Stock | F | 1358 | $12.23 | Disposed | 28671 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $12.34, inclusive. The reporting person undertakes to provide to AngioDynamics, Inc., any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The exempt disposition of 1,358 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 24, 2015.